The European Commission on Tuesday said it had approved the proposed merger between U.S. healthcare information firm IMS Health and U.S. contract medical research provider Quintiles.
The Commission said the proposed transaction would raise no competition concerns.
(Reporting by Alissa de Carbonnel, editing by Julia Fioretti).
Recent Articles on M&A
Source: Reuters.com
